Is this you?
Request access for Innovative Clinical Research with your @icrresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Innovative Clinical Research
Unclaimed profileIndependent Site · Tennessee · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall77Recruit57Ops80Sponsor94Ther84
Performance (observed)
Historical trials
552
Completed
354
Terminated/Withdrawn
97
Completion rate
78%
Active now
91
Phase 2
188
Phase 3
306
Realized enrollment
491,977
First study year
2001
Years active
25
Match confidence
high
Enrollment velocity (inf)
19,679
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
492
States
Tennessee
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Pfizer; AbbVie; Eli Lilly and Company; Hoffmann-La Roche; Janssen Research & Development, LLC; Merck Sharp & Dohme LLC
CROs
Acrotech Biopharma Inc.; Astrum CRO, S.L.; IQVIA Biotech; IQVIA Pty Ltd; Medpace, Inc.; PPD Development, LP
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
mkosinski@ICRresearch.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall77
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.